by James Radke, PhD | Mar 25, 2022
Jonathan Wall, PhD, Professor and Director of the University of Tennessee Graduate School of Medicine’s Amyloidosis and Cancer Theranostics Program and Co-founder & Interim Chief Scientific Officer at Attralus, gives an overview of immunoglobulin light...
by James Radke, PhD | Mar 24, 2022
Giacomo Chiesi, Head of Chiesi Global Rare Diseases, gives an overview of alpha mannosidosis. As Mr. Chiesi explains, alpha mannosidosis is a rare lysosomal storage disorder caused by a deficiency in the enzyme alpha-D-mannosidase. This enzyme is essential for...
by James Radke, PhD | Mar 11, 2022
Jonathan Bernstein, MD, Professor of Medicine at the University of Cincinnati, hosts a 15-minute certified continuing medical education program summarizing the latest information about hereditary angioedema (HAE) that was presented at the American College of Allergy,...
by James Radke, PhD | Mar 3, 2022
Rachael Grace, MD, Associate Professor, Harvard Medical School, hosts our latest CME program highlighting the latest research about pyruvate kinase (PK) deficiency presented at ASH 2021 and provides expert analysis of its clinical relevance for busy members of...
by James Radke, PhD | Feb 26, 2022
This Monday, many bridges, buildings, water falls, etc will be lit up to celebrate the innovation, courage, fortitude, and inspiration that embodies the rare disease community – from the strength of the patients and caregivers, to the empathy and compassion of health...
